Nuclear Medicine & Molecular Imaging Clinical Trials

Showing 1 - 12 of 12 trials

Study Title Prinicipal Investigator Stanford Study Status
F18 DCFPyL PET/CT in Imaging Participants With Recurrent Prostate Cancer

Andrei Iagaru

Recruiting
68-Ga-RM2 PET/MRI in Imaging Patients With Estrogen Receptor-Positive Breast Cancer

Andrei Iagaru

Recruiting
Gallium Ga 68 DOTA-NeoBOMB1 and Gallium Ga 68 PSMA-R2 PET/MRI in Diagnosing Participants With Recurrent Prostate Cancer

Andrei Iagaru

Recruiting
Integrin Alpha-v-Beta and [18F]-R01-MG-F2 PET/CT in Measuring Response in Patients With Pancreatic Cancer and Healthy Volunteers

Andrei Iagaru

Recruiting
68Ga-RM2 PET/CT in Detecting Regional Nodal and Distant Metastases in Patients With Intermediate or High-Risk Prostate Cancer

Andrei Iagaru

Recruiting
Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT Recruiting
A Pilot Study of 68-Ga PSMA 11 PET/MRI and 68-Ga RM2 PET/MRI for Evaluation of Prostate Cancer Response to HIFU or HDR Therapy

Andrei Iagaru

Recruiting
18F-FSPG PET/MRI or PET/CT Imaging of Cardiac Sarcoidosis or Inflammation

Andrei Iagaru

Recruiting
68Ga-RM2 PET/MRI in Biochemically Recurrent Prostate Cancer

Andrei Iagaru

Recruiting
A Pilot Study of 68Ga PSMA 11 PET/MRI and 68Ga RM2 PET/MRI for Biopsy Guidance in Patients With Suspected Prostate Cancer

Andrei Iagaru

Recruiting
[177Lu]-NeoB in Patients With Advanced Solid Tumors and With [68Ga]-NeoB Lesion Uptake

Andrei Iagaru

Recruiting
HDR Brachytherapy 68-Ga-RM2 PET, 68-Ga-PSMA-11 PET &Multi Parametric MRI in Prostate Cancer

Andrei Iagaru

Recruiting